Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

We examined the meaning of metabolically active lesions on 1-month restaging nuclear imaging of patients with relapsed/refractory large B-cell lymphoma receiving axicabtagene ciloleucel (axi-cel) by assessing the relationship between total metabolic tumor volume (MTV) on positron emission tomography...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Erin A., Kimmel, Gregory J., Frank, Matthew J., Bukhari, Ali, Hossain, Nasheed M., Jain, Michael D., Dahiya, Saurabh, Miklos, David B., Altrock, Philipp M., Locke, Frederick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448428/
https://www.ncbi.nlm.nih.gov/pubmed/37126659
http://dx.doi.org/10.1182/bloodadvances.2022009426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448428/
https://www.ncbi.nlm.nih.gov/pubmed/37126659
http://dx.doi.org/10.1182/bloodadvances.2022009426

Ejemplares similares